← FDA DRUG APPROVALS

FDA ANDA · ANDA061885

TRIMOX

Sponsor: APOTHECON

APPLICATION
ANDA061885
TYPE
ANDA
ORIGINAL APPROVAL
1974-12-10
LATEST ACTION
2002-05-23
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

TRIMOXDiscontinued
AMOXICILLIN 500MG · CAPSULE · ORAL
TRIMOXDiscontinued
AMOXICILLIN 250MG · CAPSULE · ORAL

Approval history

2002-05-23Manufacturing (CMC) · Supplement 3AP
1999-07-30Manufacturing (CMC) · Supplement 2AP
1999-02-18Labeling · Supplement 1AP
1974-12-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →